Factors influencing the immunogenicity of influenza vaccines

References

• Hswen Y, Brownstein JS, Liu J, Hawkins JB. Use of a Digital Health Application for Influenza Surveillance in China. Am J Public Health. 2017 Jul;107(7):1130–36. PMID:28520492. doi:10.2105/ajph.2017.303767.
   PubMed Web of Science ®Google Scholar
• Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, Ramakrishnan U. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med. 2011 May;8(5):e1000441. PMID:21655318. doi:10.1371/journal.pmed.1000441.
   PubMed Web of Science ®Google Scholar
• Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine. 2017 Jan 23;35(4):521–28. doi:10.1016/j.vaccine.2016.12.012. PMID:28024955.
   PubMed Web of Science ®Google Scholar
• Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol. 2010 Jun;23(3):305–11. doi:10.1097/WCO.0b013e328338f6c9. PMID:20455276.
   PubMed Web of Science ®Google Scholar
• Togashi T, Matsuzono Y, Narita M, Morishima T. Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res. 2004 Jul;103(1–2):75–78. PMID:15163492. doi:10.1016/j.virusres.2004.02.016.
   PubMed Web of Science ®Google Scholar
• Britton PN, Dale RC, Blyth CC, Macartney K, Crawford NW, Marshall H, Clark JE, Elliott EJ, Webster RI, Cheng AC, et al. Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013-2015. Pediatr Infect Dis J. 2017 Nov;36(11):1021–26. doi:10.1097/inf.0000000000001650. PMID:28654561.
   PubMed Web of Science ®Google Scholar
• Feng L, Shay DK, Jiang Y, Zhou H, Chen X, Zheng Y, Jiang L, Zhang Q, Lin H, Wang S, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ. 2012 Apr 1;90(4):279–288b. doi:10.2471/blt.11.096958. PMID:22511824.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Viboud C, Taylor RJ. Effectiveness of influenza vaccination. N Engl J Med. 2007 Dec 27;357(26):2729–30. author reply 2730-2721. PMID:18163274..
   PubMedGoogle Scholar
• Herrera GA, Iwane MK, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves SS, Gargiullo P, Bridges CB. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: colorado, United States, 2003-2004. Vaccine . 2007 Jan 2;25(1):154–60. doi:10.1016/j.vaccine.2006.05.129.  PMID:17064823.
   PubMed Web of Science ®Google Scholar
• Morimoto N, Takeishi K. Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis. Vaccine. 2018 Feb 8;36(7):949–57. doi:10.1016/j.vaccine.2018.01.023. PMID:29373191.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012 Jan;12(1):36–44. PMID:22032844. doi:10.1016/s1473-3099(11)70295-x.
   PubMed Web of Science ®Google Scholar
• Dominguez A, Godoy P, Torner N. The Effectiveness of Influenza Vaccination in Different Groups. Expert Rev Vaccines. 2016 Jun;15(6):751–64. PMID:26775669. doi:10.1586/14760584.2016.1142878.
   PubMed Web of Science ®Google Scholar
• Castrucci MR. Factors affecting immune responses to the influenza vaccine. Hum Vaccin Immunother. 2018 Mar 4;14(3):637–46. doi:10.1080/21645515.2017.1338547. PMID:28617077.
   PubMed Web of Science ®Google Scholar
• Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, Bunce M, Welsh KI, Marshall SE, Oxford J. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis. 2002 Jan 1;185(1):114–17. doi:10.1086/338014. PMID:11756990.
   PubMed Web of Science ®Google Scholar
• Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 8;168(22):2405–14. doi:10.1001/archinternmed.2008.513. PMID:19064822..
   PubMedGoogle Scholar
• Coleman BL, Kuster SP, Gubbay J, Scheifele D, Li Y, Low D, Crowcroft N, Mazzulli T, Shi L, Halperin SA, et al. Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology. 2012 Apr;31(4):591–97. doi:10.1007/s10096-011-1352-5. PMID:21796343.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014 Aug 14;371(7):635–45. doi:10.1056/NEJMoa1315727. PMID:25119609.
   PubMed Web of Science ®Google Scholar
• Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM, Mahmud SM. Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis. Vaccine. 2017 May 15;35(21):2775–80. doi:10.1016/j.vaccine.2017.03.092. PMID:28431815.
   PubMed Web of Science ®Google Scholar
• Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design. Vaccine. 2018 Oct 29;36(45):6683–87. doi:10.1016/j.vaccine.2018.09.050. PMID:30287157.
   PubMed Web of Science ®Google Scholar
• Halasa NB, Gerber MA, Berry AA, Anderson EL, Winokur P, Keyserling H, Eckard AR, Hill H, Wolff MC, McNeal MM, et al. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. J Pediatric Infect Dis Soc. 2015 Sep;4(3):214–24. doi:10.1093/jpids/piu061. PMID:26334249.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Hottes TS, Chong M, De Serres G, Scheifele DW, Ward BJ, Halperin SA, Janjua NZ, Chan T, Sabaiduc S, et al. Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics. 2011 Aug;128(2):e276–289. doi:10.1542/peds.2010-2777. PMID:21768314.
   PubMed Web of Science ®Google Scholar
• Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP. Fluzone® High-Dose Influenza Vaccine. Expert Rev Vaccines. 2016 Dec;15(12):1495–505. PMID:27813430. doi:10.1080/14760584.2016.1254044.
   PubMed Web of Science ®Google Scholar
• Hakim H, Allison KJ, Van de Velde LA, Tang L, Sun Y, Flynn PM, McCullers JA. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection. Vaccine. 2016 Jun 8;34(27):3141–48. doi:10.1016/j.vaccine.2016.04.053. PMID:27129426.
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008 Sep 1;198(5):650–58. doi:10.1086/590434. PMID:18652550.
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Vaccine. 2013 May 1;31(19):2358–65. doi:10.1016/j.vaccine.2013.03.008.  PMID:23499604.
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age. Vaccine. 2013 Dec 5;31(50):6034–40. doi:10.1016/j.vaccine.2013.09.012.  PMID:24055306.
   PubMed Web of Science ®Google Scholar
• Loubet P, Loulergue P, Galtier F, Launay O. Seasonal influenza vaccination of high-risk adults. Expert Rev Vaccines. 2016 Dec;15(12):1507–18. PMID:27169689. doi:10.1080/14760584.2016.1188696.
   PubMed Web of Science ®Google Scholar
• Sano K, Ainai A, Suzuki T, Hasegawa H. The road to a more effective influenza vaccine: up to date studies and future prospects. Vaccine. 2017 Sep 25;35(40):5388–95. doi:10.1016/j.vaccine.2017.08.034. PMID:28866292.
   PubMed Web of Science ®Google Scholar
• Mohn KG, Smith I, Sjursen H, Cox RJ. Immune responses after live attenuated influenza vaccination. Hum Vaccin Immunother. 2018 Mar 4;14(3):571–78. doi:10.1080/21645515.2017.1377376. PMID:28933664.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Heinonen S. Effectiveness and safety of influenza vaccination in children. European Perspective Vaccine. 2011 Oct 6;29(43):7529–34. doi:10.1016/j.vaccine.2011.08.011. PMID:21820481.
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respi Viruses. 2011 Mar;5(2):67–75. PMID:21306569. doi:10.1111/j.1750-2659.2010.00183.x.
   PubMed Web of Science ®Google Scholar
• King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. Vaccine. 2018 Feb 21;36(9):1214–19. doi:10.1016/j.vaccine.2018.01.016. PMID:29395525.
   PubMed Web of Science ®Google Scholar
• Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald CA, Nowalk MP, Susick M, Moehling K, Spencer S, et al. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination. Clinical and Vaccine Immunology CVI. 2016 Oct;23(10):831–39. doi:10.1128/cvi.00297-16. PMID:27558294.
   PubMedGoogle Scholar
• Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis. 2011 Nov 15;204(10):1475–82. doi:10.1093/infdis/jir561. PMID:21949042.
   PubMed Web of Science ®Google Scholar
• Ang JC, Wang B, Wang JJF, Zeng PYF. Comparative Immunogenicity of the 2014-2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children. Vaccines (Basel). 2019 Aug 12;7(3):87. doi:10.3390/vaccines7030087. PMID:31408963.
   Google Scholar
• Bandell A, Woo J, Coelingh K. Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference. Expert Rev Vaccines. 2011 Aug;10(8):1131–41. doi:10.1586/erv.11.73. PMID:21854309.
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Manenti A, Kistner O, Trombetta C. How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions. Influenza Other Respir Viruses. Sep 2019;135:429–37. doi:10.1111/irv.12664. PMID:31225704
   Google Scholar
• Leong KW, Ding JL. The unexplored roles of human serum IgA. DNA Cell Biol. 2014 Dec;33(12):823–29. PMID:25188736. doi:10.1089/dna.2014.2639.
   PubMed Web of Science ®Google Scholar
• Brokstad KA, Cox RJ, Eriksson JC, Olofsson J, Jonsson R, Davidsson A. High prevalence of influenza specific antibody secreting cells in nasal mucosa. Scand J Immunol. 2001 Jul-Aug;54(1–2):243–7. doi:10.1046/j.1365-3083.2001.00947.x. PMID:11439173.
   Web of Science ®Google Scholar
• Zens KD, Chen JK, Farber DL. Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. JCI Insight. 2016 Jul 7;1(10). doi:10.1172/jci.insight.85832. PMID:27468427.
   PubMed Web of Science ®Google Scholar
• Panapasa JA, Cox RJ, Mohn KG, Aqrawi LA, Brokstad KA. The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. Hum Vaccin Immunother. 2015;11(7):1663–72. doi:10.1080/21645515.2015.1032486. PMID:26148331.
   PubMed Web of Science ®Google Scholar
• Mohn KG, Brokstad KA, Pathirana RD, Bredholt G, Jul-Larsen Å, Trieu MC, Lartey SL, Montomoli E, Tøndel C, Aarstad HJ, et al. Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils. J Infect Dis. 2016 Sep 1;214(5):722–31. doi:10.1093/infdis/jiw230. PMID:27247344.
   PubMed Web of Science ®Google Scholar
• Mohn KG, Bredholt G, Brokstad KA, Pathirana RD, Aarstad HJ, Tøndel C, Cox RJ. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. J Infect Dis. 2015 May 15;211(10):1541–49. doi:10.1093/infdis/jiu654. PMID:25425696.
   PubMed Web of Science ®Google Scholar
• Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, Truscott SM, Abate G, Sakala IG, Edwards KM, Creech CB, et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis. 2011 Sep 15;204(6):845–53. doi:10.1093/infdis/jir436. PMID:21846636..
   PubMed Web of Science ®Google Scholar
• Cox MM, Hollister JR. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals: Journal of the International Association of Biological Standardization. 2009 Jun;37(3):182–89. PMID:19297194. doi:10.1016/j.biologicals.2009.02.014.
   PubMed Web of Science ®Google Scholar
• King JC Jr., Cox MM, Reisinger K, Hedrick J, Graham I, Patriarca P. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months. Vaccine . 2009 Nov 5;27(47):6589–94. doi:10.1016/j.vaccine.2009.08.032. PMID:19716456.
   PubMed Web of Science ®Google Scholar
• Dunkle LM, Izikson R, Patriarca PA, Goldenthal KL, Cox M, Treanor JJ. Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial Pediatrics. May 2018;141(5). PMID:29610401. doi:10.1542/peds.2017-3021.
   Google Scholar
• Baxter R, Patriarca PA, Ensor K, Izikson R, Goldenthal KL, Cox MM. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Vaccine. 2011 Mar 9;29(12):2272–78. doi:10.1016/j.vaccine.2011.01.039. PMID:21277410.
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis. 2006 May 1;193(9):1223–28. doi:10.1086/503050. PMID:16586358.
   PubMed Web of Science ®Google Scholar
• Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine. 2011 Oct 13;29(44):7733–39. doi:10.1016/j.vaccine.2011.07.128. PMID:21835220.
   PubMed Web of Science ®Google Scholar
• Xu H, Ruwona TB, Thakkar SG, Chen Y, Zeng M, Cui Z. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses. Hum Vaccin Immunother. 2017 Nov 2;13(11):2688–94. doi:10.1080/21645515.2017.1365995. PMID:28933668.
   PubMed Web of Science ®Google Scholar
• Domnich A, Arata L, Amicizia D, Puig-Barbera J, Gasparini R, Panatto D. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. PMID:28024956. 2017 Jan 23;35(4):513–20. doi:10.1016/j.vaccine.2016.12.011.
   PubMed Web of Science ®Google Scholar
• Cohet C, van der Most R, Bauchau V, Bekkat-Berkani R, Doherty TM, Schuind A. Tavares Da Silva F, Rappuoli R, Garçon N, Innis BL. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine. 2019 May 21;37(23):3006–21. doi:10.1016/j.vaccine.2019.04.048. PMID:31031030.
   PubMed Web of Science ®Google Scholar
• Wilkins AL, Kazmin D, Napolitani G, Clutterbuck EA, Pulendran B, Siegrist CA, Pollard AJ. AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Front Immunol. 2017;8::1760. doi:10.3389/fimmu.2017.01760. PMID:29326687.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis. 2012 Sep 15;206(6):811–20. doi:10.1093/infdis/jis427. PMID:22782949.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forsten A, Arora A, Tsai T, Clemens R. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine. Hum Vaccin Immunother. 2015;11(8):2102–12. doi:10.1080/21645515.2015.1044167. PMID:26091244.
   PubMed Web of Science ®Google Scholar
• Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009 Dec 17;361(25):2424–35. doi:10.1056/NEJMoa0907650. PMID:19745215.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang J, Han T, Liu C, Li X, Yan L, Yang B, Yang X. Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis. Medicine. 2020 Feb;99(7):e19095. PMID:32049815. doi:10.1097/md.0000000000019095.
   PubMed Web of Science ®Google Scholar
• Patel SS, Bizjajeva S, Heijnen E, Oberye J. MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: safety and immunogenicity in young children at risk of influenza complications. International Journal of Infectious Diseases. 2019 Aug;85S:S18–S25. doi:10.1016/j.ijid.2019.04.023. PMID:31051279.
   Web of Science ®Google Scholar
• Lindert K, Leav B, Heijnen E, Barrett J, Nicolay U, Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases. Aug 2019;85s;S10–s17. PMID:30904674. doi:10.1016/j.ijid.2019.03.020.
   PubMed Web of Science ®Google Scholar
• Patel SS, Bizjajeva S, Lindert K, Heijnen E, Oberye J. Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children. International Journal of Infectious Diseases. 2019 Aug;85S:S26-S38. doi:10.1016/j.ijid.2019.05.009. PMID:31096055.
   Web of Science ®Google Scholar
• Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, Laframboise C, Al Adhami MJ, Khaliq Y, Seguin I, et al. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine. 2004 Aug 13;22(23–24):3136–43. doi:10.1016/j.vaccine.2004.01.058. PMID:15297066.
   PubMed Web of Science ®Google Scholar
• Tregoning JS, Russell RF, Kinnear E. Adjuvanted influenza vaccines. Hum Vaccin Immunother. 2018 Mar 4;14(3):550–64. doi:10.1080/21645515.2017.1415684. PMID:29232151.
   PubMed Web of Science ®Google Scholar
• Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med. 1995 Dec;1(12):1279–83. doi:10.1038/nm1295-1279. PMID:7489409.
   PubMed Web of Science ®Google Scholar
• Huygen K, Palfliet K. Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of One Major Autosomal Locus and Additional Sexual Influences Cellular Immunology. 1984 Apr 15;85(1):75–81. PMID:6424949.
   Google Scholar
• Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015 Jun;14(3):309–21. PMID:25720438. doi:10.1111/acel.12326.
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. Oct 2016;1610:626–38. 10.1038/nri.2016.90. PMID:27546235.
   Google Scholar
• Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869–74. doi:10.1073/pnas.1321060111. PMID:24367114.
   PubMed Web of Science ®Google Scholar
• Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun Jul 2009;105:509–16. 10.1038/gene.2009.12. PMID:19279650
   Google Scholar
• Lu FX, Abel K, Ma Z, Rourke T, Lu D, Torten J, McChesney M, Miller CJ. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol. 2002 Apr;128(1):10–20. PMID:11982585. doi:10.1046/j.1365-2249.2002.01780.x.
   PubMed Web of Science ®Google Scholar
• Potluri T, Fink AL, Sylvia KE, Dhakal S. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29. PMID:31312529. doi:10.1038/s41541-019-0124-6.
   Google Scholar
• Nguyen DC, Masseoud F, Lu X, Scinicariello F, Sambhara S, Attanasio R. 17beta-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model. Vaccine. 2011 Mar 21;29(14):2515–18. doi:10.1016/j.vaccine.2011.01.080. PMID:21310192.
   PubMed Web of Science ®Google Scholar
• WHO. Vaccines against influenza WHO position paper - November 2012. Releve epidemiologique hebdomadaire. 2012 Nov 23;87(47):461–76. English, French.  PMID:23210147.
   PubMedGoogle Scholar
• Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol. 2007 Jan;81(1):215–28. PMID:17050593. doi:10.1128/jvi.01957-06.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhivaki D, Lo-Man R. Unique aspects of the perinatal immune system. Nat Rev Immunol. 2017 Aug;17(8):495–507. PMID:28627520. doi:10.1038/nri.2017.54.
   PubMed Web of Science ®Google Scholar
• Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol. 2010 Nov;162(2):271–79. doi:10.1111/j.1365-2249.2010.04206.x. PMID:20854328.
   PubMed Web of Science ®Google Scholar
• Saso A, Kampmann B. Vaccine responses in newborns. Semin Immunopathol. 2017 Nov;39(6):627–42. PMID:29124321. doi:10.1007/s00281-017-0654-9.
   PubMed Web of Science ®Google Scholar
• Yu JC, Khodadadi H, Malik A, Davidson B, Salles ÉDSL, Bhatia J, Hale VL, Baban B. Innate Immunity of Neonates and Infants. Front Immunol. 2018;9:1759. doi:10.3389/fimmu.2018.01759. PMID:30105028.
   PubMed Web of Science ®Google Scholar
• Adlerberth I. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutrition workshop series. Paediatric Programme. 2008;62:13–29;discussion 29–33. doi:10.1159/000146245. PMID:18626190.
   Google Scholar
• Egawa Y, Ohfuji S, Fukushima W, Yamazaki Y, Morioka T, Emoto M, Maeda K, Inaba M, Hirota Y. Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c. Hum Vaccin Immunother. 2014;10(5):1187–94. doi:10.4161/hv.28252. PMID:24717236.
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159–69. doi:10.1016/j.vaccine.2005.08.105.
   PubMed Web of Science ®Google Scholar
• Kowalczyk D, Szymański K, Cieślak K, Hallmann-Szelińska E, Brydak LB. Circulation of Influenza Virus in the 2015/2016 Epidemic Season in Poland: serological Evaluation of Anti-hemagglutinin Antibodies. Adv Exp Med Biol . 2019;1150:77–82. doi:10.1007/5584_2018_271. PMID:30276725.
   PubMed Web of Science ®Google Scholar
• Simpson CR, Lone N, Kavanagh K, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Health Services and Delivery Research. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study - exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine. Southampton (UK): NIHR Journals Library; 2013.
   Google Scholar
• Sadighi Akha AA. Aging and the immune system: an overview. J Immunol Methods. 2018 Dec;463:21–26. doi:10.1016/j.jim.2018.08.005. PMID:30114401.
   PubMed Web of Science ®Google Scholar
• Pawelec G. Age and immunity: what is “immunosenescence”? Exp Gerontol. 2017;105:4–9. doi:10.1016/j.exger.2017.10.024.
   PubMed Web of Science ®Google Scholar
• Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immunity & Ageing. 2019;16:1–16.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Annals of allergy, asthma & immunology. Official Publication of the American College of Allergy, Asthma, & Immunology. 2010 Mar;104(3):183–190;quiz 190–182, 210. PMID:20377107. doi:10.1016/j.anai.2009.11.009.
   Google Scholar
• Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. Journal of Immunology (Baltimore, Md : 1950). 2010 Mar 1;184(5):2518–27. doi:10.4049/jimmunol.0901022. PMID:20100933.
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013 May;14(5):428–36. PMID:23598398. doi:10.1038/ni.2588.
   PubMed Web of Science ®Google Scholar
• Haynes L, Lefebvre JS. Age-related Deficiencies in Antigen-Specific CD4 T cell Responses: lessons from Mouse Models. Aging Dis. 2011 Oct;2(5):374–81. PMID:22396889.
   PubMed Web of Science ®Google Scholar
• Sagawa M, Kojimahara N, Otsuka N, Kimura M, Yamaguchi N. Immune response to influenza vaccine in the elderly: association with nutritional and physical status. Geriatr Gerontol Int. 2011 Jan;11(1):63–68. PMID:20738411. doi:10.1111/j.1447-0594.2010.00641.x.
   PubMed Web of Science ®Google Scholar
• Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, Holland LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. 2005 [Aug 2012];36(8):1072–77. doi:10.1038/ijo.2011.208. PMID:22024641.
   Google Scholar
• Honce R, Schultz-Cherry S. Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness. J Travel Med. 2019 May 10;26(3). doi:10.1093/jtm/taz020. PMID:30924873.
   PubMed Web of Science ®Google Scholar
• Rebeles J, Green WD, Alwarawrah Y, Nichols AG, Eisner W, Danzaki K, MacIver NJ, Beck MA. Obesity-Induced Changes in T-Cell Metabolism Are Associated With Impaired Memory T-Cell Response to Influenza and Are Not Reversed With Weight Loss. J Infect Dis PMID:30535161. 2019 Apr 19;219(10):1652–61. doi:10.1093/infdis/jiy700.
   PubMed Web of Science ®Google Scholar
• Zhang AJ, To KK, Li C, Lau CC, Poon VK, Chan CC, Zheng BJ, Hung IF, Lam KS, Xu A, et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J Infect Dis. 2013 Apr 15;207(8):1270–80. doi:10.1093/infdis/jit031. PMID:23325916..
   PubMed Web of Science ®Google Scholar
• Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG, Noah TL, Weir SS, Beck MA. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring, Md). 2013 Nov;21(11):2377–86 . doi:10.1002/oby.20383. PMID:23512822.
   PubMed Web of Science ®Google Scholar
• Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, Das J, Wang H, Guthmiller J, Zheng NY, et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019 Sep 5;178(6):1313–1328.e1313. doi:10.1016/j.cell.2019.08.010. PMID:31491384.
   PubMed Web of Science ®Google Scholar
• de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica. 2011 Feb;96(2):307–14. doi:10.3324/haematol.2010.032664. PMID:20971824.
   PubMed Web of Science ®Google Scholar
• Meier S, Bel M, L’Huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Posfay-Barbe K, Siegrist CA. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine. 2011 Apr 27;29(19):3548–57. doi:10.1016/j.vaccine.2011.02.094. PMID:21419775.
   PubMed Web of Science ®Google Scholar
• Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant. 2009 Oct;9(10):2346–54. PMID:19656126. doi:10.1111/j.1600-6143.2009.02787.x.
   PubMed Web of Science ®Google Scholar
• Brakemeier S, Schweiger B, Lachmann N, Glander P, Schonemann C, Diekmann F, Neumayer HH, Budde K. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix((R))) in renal transplant recipients. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2012 Jan;27(1):423–28 . doi:10.1093/ndt/gfr278. PMID:21613386
   PubMed Web of Science ®Google Scholar
• Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2001 Apr;7(4):311–13. PMID:11303290. doi:10.1053/jlts.2001.23010.
   PubMed Web of Science ®Google Scholar
• Diepersloot RJ, Bouter KP, Beyer WE, Hoekstra JB, Masurel N. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia. 1987 Jun;30(6):397–401. doi:10.1007/BF00292541. PMID:3678660.
   PubMed Web of Science ®Google Scholar
• el-Madhun AS, Cox RJ, Seime A, Sovik O, Haaheim LR. Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study. Vaccine. 1998 Jan-Feb;16(2–3):156–60. doi:10.1016/S0264-410X(97)88328-4. PMID:9607024.
   PubMed Web of Science ®Google Scholar
• Saito T, Ohfuji S, Matsumura T, Saito T, Maeda K, Maeda A, Fukushima W, Fujimura H, Sakoda S, Hirota Y. Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular Dystrophy. Internal Medicine (Tokyo, Japan). 2015;54(10):1199–205. doi:10.2169/internalmedicine.54.1186. PMID:25986256.
   PubMed Web of Science ®Google Scholar
• Agrati C, Gioia C, Castilletti C, Lapa D, Berno G, Puro V, Carletti F, Cimini E, Nisii C, Castellino F, et al. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1606–16. doi:10.1089/aid.2011.0371. PMID:22439734.
   PubMed Web of Science ®Google Scholar
• Godoy P, Castilla J, Soldevila N, Mayoral JM, Toledo D, Martin V, Astray J, Egurrola M, Morales-Suarez-Varela M, Dominguez A. Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly. Eur J Public Health. 2018 Feb 1;28(1):150–55. doi:10.1093/eurpub/ckx130. PMID:29020390.
   PubMed Web of Science ®Google Scholar
• Godoy P, Castilla J, Mayoral JM, Delgado-Rodriguez M, Martin V, Astray J, Soldevila N, Gonzalez-Candelas F, Castro A, Baricot M, et al. Smoking may increase the risk of hospitalization due to influenza. Eur J Public Health. 2016 Oct;26(5):882–87. doi:10.1093/eurpub/ckw036. PMID:27085194.
   PubMed Web of Science ®Google Scholar
• Horvath KM, Herbst M, Zhou H, Zhang H, Noah TL, Jaspers I. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus. Respir Res. 2011 Aug 4;12(1):102. doi:10.1186/1465-9921-12-102. PMID:21816072.
   PubMedGoogle Scholar
• Tejero JD, Armand NC, Finn CM, Dhume K, Strutt TM, Chai KX, Chen LM, McKinstry KK. Cigarette smoke extract acts directly on CD4 T cells to enhance Th1 polarization and reduce memory potential. Cell Immunol. 2018 Sep;331:121–29. doi:10.1016/j.cellimm.2018.06.005. PMID:29935764.
   PubMed Web of Science ®Google Scholar
• Bhat TA, Kalathil SG, Bogner PN, Miller A, Lehmann PV, Thatcher TH. Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections. J Immunol. 2018 Apr 15;200(8);2927–40. doi:10.4049/jimmunol.1701417. PMID:29555783.
   Google Scholar
• Duffney PF, McCarthy CE, Nogales A, Thatcher TH. Cigarette smoke dampens antiviral signaling in small airway epithelial cells by disrupting TLR3 cleavage. Am J Physiol Lung Cell Mol Physiol. 2018 Mar 1;314(3);L505–l513. doi:10.1152/ajplung.00406.2017. PMID:29351447.
   Google Scholar
• HuangFu WC, Liu J, Harty RN, Fuchs SY. Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett. 2008 Sep 22;582(21–22):3206–10. doi:10.1016/j.febslet.2008.08.013. PMID:18722370.
   PubMed Web of Science ®Google Scholar
• Szabo G, Saha B. Alcohol’s Effect on Host Defense. Alcohol Research: Current Reviews. 2015;37(2):159–70. PMID:26695755.
   PubMed Web of Science ®Google Scholar
• Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:242–51. doi:10.1016/j.pnpbp.2015.09.001. PMID:26375241.
   PubMed Web of Science ®Google Scholar
• Chen P, Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut Liver. 2014 May;8(3):237–41. PMID:24827618. doi:10.5009/gnl.2014.8.3.237.
   PubMed Web of Science ®Google Scholar
• Jamieson AM. Influence of the microbiome on response to vaccination. Hum Vaccin Immunother. 2015;11(9):2329–31. doi:10.1080/21645515.2015.1022699. PMID:26090701.
   PubMed Web of Science ®Google Scholar
• Negi S, Das DK, Pahari S, Nadeem S, Agrewala JN. Potential Role of Gut Microbiota in Induction and Regulation of Innate Immune Memory. Front Immunol. 2019;10:2441. doi:10.3389/fimmu.2019.02441. PMID:31749793.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Curtis N. The influence of the intestinal microbiome on vaccine responses. Vaccine . 2018 Jul 16;36(30):4433–39. doi:10.1016/j.vaccine.2018.04.066. PMID:29909134.
   PubMed Web of Science ®Google Scholar
• Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, Hakimpour P, Gill KP, Nakaya HI, Yarovinsky F, et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity. 2014 Sep 18;41(3):478–92. doi:10.1016/j.immuni.2014.08.009. PMID:25220212.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Huda S, Sinha Babu SP. Toll-like receptor polymorphism in host immune response to infectious diseases. A Review. 2019 Jul;90(1):e12771. PMID:31054156. doi:10.1111/sji.12771.
   Google Scholar
• Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. Journal of Immunology. (Baltimore, Md.: 1950).Jun1 2004;17211:6922–30. doi:10.4049/jimmunol.172.11.6922. PMID:15153511.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol. 2017 Dec;14(12):1017–19. PMID:29151579. doi:10.1038/cmi.2017.122.
   PubMed Web of Science ®Google Scholar
• Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine. 2012 Jan 5;30(2):466–74. doi:10.1016/j.vaccine.2011.10.058. PMID:22051136.
   PubMed Web of Science ®Google Scholar
• Kim JR, Holbrook BC, Hayward SL, Blevins LK, Jorgensen MJ, Kock ND, De Paris K, D’Agostino RB Jr., Aycock ST, Mizel SB, et al. Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates. J Virol. 2015 Jul;89(14):7291–303. doi:10.1128/jvi.00549-15. PMID:25948746.
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine. 2010 Dec 6;28(52):8268–74. doi:10.1016/j.vaccine.2010.10.009. PMID:20969925.
   PubMed Web of Science ®Google Scholar
• Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, Ozer K, Tussey L, Shaw A. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine. 2011 Jul 12;29(31):4897–902. doi:10.1016/j.vaccine.2011.05.001. PMID:21596084.
   PubMed Web of Science ®Google Scholar
• Cui B, Liu X, Fang Y, Zhou P, Zhang Y, Wang Y. Flagellin as a vaccine adjuvant. Expert Rev Vaccines. 2018 Apr;17(4):335–49. PMID:29580106. doi:10.1080/14760584.2018.1457443.
   PubMed Web of Science ®Google Scholar
• Ciabattini A, Olivieri R, Lazzeri E, Medaglini D. Role of the Microbiota in the Modulation of Vaccine Immune Responses. Front Microbiol. 2019;10:1305. doi:10.3389/fmicb.2019.01305. PMID:31333592.
   PubMed Web of Science ®Google Scholar
• Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, Zhang XF, Pan HX, Meng FY, Hu YM, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009 Dec 17;361(25):2414–23. doi:10.1056/NEJMoa0908535. PMID:19846844.
   PubMed Web of Science ®Google Scholar
• Monto AS, Malosh RE, Petrie JG, Martin ET. The Doctrine of Original Antigenic Sin: separating Good From Evil. J Infect Dis. 2017 Jun 15;215(12):1782–88. doi:10.1093/infdis/jix173. PMID:28398521.
   PubMed Web of Science ®Google Scholar
• Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J Virol. 2015 Mar;89(6):3308–17. PMID:25589639. doi:10.1128/jvi.02871-14.
   PubMed Web of Science ®Google Scholar
• Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB. Influence of prior influenza vaccination on antibody and B-cell responses. PloS One. 2008 Aug 20;3(8):e2975. doi:10.1371/journal.pone.0002975. PMID:18714352.
   PubMed Web of Science ®Google Scholar
• Sperling RS, Engel SM, Wallenstein S, Kraus TA, Garrido J, Singh T, Kellerman L, Moran TM. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol. 2012 Mar;119(3):631–39. PMID:22353963. doi:10.1097/AOG.0b013e318244ed20.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Naleway AL, Fry AM, Ball S, Spencer S, Reynolds S, Bozeman S, Levine MZ, Katz JM, Gaglani M. Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. Vaccine. 2016;34(7):981–88. doi:10.1016/j.vaccine.2015.10.119.
   PubMed Web of Science ®Google Scholar
• Khurana S, Hahn M, Coyle EM, King LR, Lin T, Treanor JJ, Sant AJ, Golding H. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans. Nat Commun. 2019;10(1):3338. doi:10.1038/s41467-019-11296-5.
   PubMedGoogle Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther. 2007 Dec;82(6):653–64. PMID:17971814.doi:10.1038/sj.clpt.6100415.
   PubMed Web of Science ®Google Scholar
• Linnik JE, Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother . PMID:26809773. 2016 Apr 2;12(4):907–15. doi:10.1080/21645515.2015.1119345.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, Boccia S. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine. 2014 Mar 26;32(15):1661–69. doi:10.1016/j.vaccine.2014.01.057. PMID:24513009.
   PubMed Web of Science ®Google Scholar
• Mert G, Sengul A, Gul HC, Karakas A, Eyigun CP. The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 2014 Feb;47(1):9–14. PMID:23523043. doi:10.1016/j.jmii.2013.01.004.
   PubMedGoogle Scholar
• Reali G. [The HLA system and the major histocompatibility complex in humans]. Pathologica. 1975 Nov–Dec;67(973–974):439–51. Italian. PMID:131932.
   Google Scholar
• Mackenzie JS, Wetherall JD, Fimmel PJ, Hawkins BR, Dawkins RL. Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens. Dev Biol Stand. Jun1 1977;39:355–62. PMID:604120.
   PubMedGoogle Scholar
• Moss AJ, Gaughran FP, Karasu A, Gilbert AS, Mann AJ, Gelder CM, Oxford JS, Stephens HA, Lambkin-Williams R. Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination. PloS One . 2013;8(8):e71376. doi:10.1371/journal.pone.0071376. PMID:23951151.
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM Immunogenetics of seasonal influenza vaccine response. Vaccine. Sep12 2008;26Suppl 4: D35-40. PMID:19230157. doi: 10.1016/j.vaccine.2008.07.065. PMID:19230157.
   Google Scholar
• Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine. 2013 Feb 4;31(7):1123–28. doi:10.1016/j.vaccine.2012.12.026. PMID:23261040.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Kumar V, Netea MG, Xavier RJ. The causes and consequences of variation in human cytokine production in health. Curr Opin Immunol. 2018 Oct;54:50–58. doi:10.1016/j.coi.2018.05.012. PMID:29913309.
   PubMed Web of Science ®Google Scholar
• Egli A, Santer DM, O’Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog. 2014 Dec;10(12):e1004556. doi:10.1371/journal.ppat.1004556. PMID:25503988..
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, White SJ, Larrabee BR, Grill DE, Jacobson RM, Poland GA. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals. Vaccine. 2014 Feb 7;32(7):881–87. doi:10.1016/j.vaccine.2013.12.009. PMID:24360890.
   PubMed Web of Science ®Google Scholar
• Qin L, Wang D, Li D, Zhao Y, Peng Y, Wellington D, Dai Y, Sun H, Sun J, Liu G, et al. High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults. Front Cell Infect Microbiol . 2018;8:134. doi:10.3389/fcimb.2018.00134. PMID:29868492.
   PubMed Web of Science ®Google Scholar
• Lei N, Li Y, Sun Q, Lu J, Zhou J, Li Z, Liu L, Guo J, Qin K, Wang H, et al. IFITM3 affects the level of antibody response after influenza vaccination. Emerging Microbes & Infections. 2020;9(1):976–87. PMID:32321380. doi:10.1080/22221751.2020.1756696.
   PubMed Web of Science ®Google Scholar
• Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Faseb J. 2012;26(7):2911–18. doi:10.1096/fj.11-190017. PMID:22490782.
   PubMed Web of Science ®Google Scholar